Technology | X-Ray | September 12, 2019

Platform includes first artificial intelligence algorithms embedded on-device to prioritize critical chest X-ray review

FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI

September 12, 2019 – GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a collection of artificial intelligence (AI) algorithms embedded on a mobile X-ray device. Built in collaboration with UC San Francisco (UCSF) using GE Healthcare’s Edison platform, the AI algorithms help to reduce the turn-around time it can take for radiologists to review a suspected pneumothorax, a type of collapsed lung.

A prioritized “STAT” X-ray can sit waiting for up to eight hours for a radiologist’s review[1]. However, when a patient is scanned on a device with Critical Care Suite, the system automatically analyzes the images by simultaneously searching for a pneumothorax. If a pneumothorax is suspected, an alert — along with the original chest X-ray — is sent directly to the radiologist for review via picture archiving and communication systems (PACS). The technologist also receives a subsequent on-device notification[2] to give awareness of the prioritized cases. Quality-focused AI algorithms simultaneously analyze and flag protocol and field-of-view errors as well as auto-rotate the images on-device. Critical Care Suite and the quality algorithms were developed using GE Healthcare’s Edison platform – which helps deploy AI algorithms quickly and securely – and deployed on the company’s Optima XR240amx system. 

“Clinicians are always looking for clinically proven methods to increase outcomes and improve the patient experience,” said Rachael Callcut, M.D., associate professor of surgery at UCSF, a surgeon at UCSF Health and director of data science for the Center for Digital Health Innovation, who partnered in the development of Critical Care Suite. “When a patient X-ray is taken, the minutes and hours it takes to process and interpret the image can impact the outcome in either direction. AI gives us an opportunity to speed up diagnosis and change the way we care for patients, which could ultimately save lives and improve outcomes.” 

Additionally, embedding Critical Care Suite on-device offers several benefits to radiologists and technologists. For critical findings, GE Healthcare’s algorithms are a fast and reliable way to ensure AI results are generated within seconds of image acquisition, without any dependency on connectivity or transfer speeds to produce the AI results. These results are then sent to the radiologist at the same time the device sends the original diagnostic image, ensuring no additional processing delay. Also, automatically running quality checks on-device integrates them into the technologist’s standard workflow and enables technologist actions – such as rejections or reprocessing – to occur at the patient’s bedside and before the images are sent to PACS. 

GE Healthcare’s Edison offering comprises applications and smart devices built using the Edison platform. The platform uses an extensive catalog of healthcare-specific developer services to enable both GE developers and select strategic partners to design, develop, manage, secure and distribute advanced applications, services and AI algorithms quickly. Edison integrates and assimilates data from multiple sources, applying analytics and AI to not only transform data, but provide actionable insights that can be deployed on medical devices, via the cloud or at the edge of the device. 

Additional partners in the development of Critical Care Suite include St. Luke’s University Health Network, Humber River Hospital and CARING - Mahajan Imaging – India. 

For more information: www.gehealthcare.com

References

1. Rachh P., Levey A.O., Lemmon A., et al. “Reducing STAT Portable Chest Radiograph Turnaround Times: A Pilot Study.” Current Problems in Diagnostic Radiology, published online June 5, 2017. https://doi.org/10.1067/j.cpradiol.2017.05.012

2. The technologist on-device notification is generated after a delay, post exam closure, and it does not provide any diagnostic information, nor is it intended to inform any clinical decision, prioritization, or action.


Related Content

News | Stroke

Dec. 18, 2025 — Brainomix, a provider of AI-powered imaging biomarkers for stroke and lung fibrosis, has announced ...

Time December 24, 2025
arrow
News | Information Technology

Dec. 16, 2025 — McCrae Tech has launched the world’s first health AI orchestrator called Orchestral. It is a health ...

Time December 23, 2025
arrow
News | RSNA 2025

Dec. 12, 2025 — At RSNA 2025, United Imaging Intelligence (UII), the AI-focused subsidiary of United Imaging Group ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Radiation Dose Management

Dec. 5, 2025 — Virtual Phantoms Inc. has launched VirtualDose DX — the company’s latest innovation in radiation dose ...

Time December 10, 2025
arrow
Feature | Radiation Oncology | Kyle Hardner

Genomics has guided personalized cancer treatments for the past two decades. Now, AI biomarkers are expanding the field ...

Time December 09, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | X-Ray

Dec. 1, 2025 – Zwanger-Pesiri Radiology, one of the most respected and technologically advanced outpatient radiology ...

Time December 03, 2025
arrow
News | Information Technology

Dec. 1, 2025 — BioSked has announced a major expansion of its Momentum scheduling platform, introducing one of the first ...

Time December 03, 2025
arrow
News | Radiology Imaging

Dec. 1, 2025 — Rad AI has launched next-generation speech recognition technology (patent pending) that dramatically ...

Time December 02, 2025
arrow
Subscribe Now